Both in Pharmaceuticals
Nuvation Bio vs Ultragenyx Pharmaceutical
Over the past year NUVB returned −9.3% and RARE returned −50.3%; their daily moves had a correlation of 0.16.
NUVB −9.3% RARE −50.3%Growth of $1, one year, split-adjusted
| Metric | NUVB | RARE |
|---|---|---|
| Price | $4.69 | $16.63 |
| Market cap | $1.65B | $1.64B |
| Today | +2.18% | +2.02% |
| 1 month | −5.3% | +14.7% |
| 6 months | −2.9% | −33.5% |
| Year to date | −47.7% | −27.7% |
| 1 year | −10.2% | −51.9% |
| Revenue growth (YoY) | +555.6% | +28.1% |
| Gross margin | 73.0% | 84.1% |
| Net margin | −198.3% | −43.0% |
| P/E (TTM) | — | — |
| Price / sales | 9.7× | 2.3× |
| Net cash | $399.4M | $292.0M |
| Dividend yield | — | — |
| Volatility (60d) | 51.1% | 128.3% |
| Short % of float | 23.9% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).